Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).

Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group.

Circ J. 2005 Sep;69(9):1016-21.

PMID:
16127179
[PubMed - indexed for MEDLINE]
Free Article
2.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial.

Circ J. 2002 Dec;66(12):1087-95.

PMID:
12499611
[PubMed - indexed for MEDLINE]
Free Article
3.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).

Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial.

Circ J. 2002 Dec;66(12):1096-100.

PMID:
12499612
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.

Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Itakura H; J-LIT Study Group.

Hypertens Res. 2005 Nov;28(11):879-87.

PMID:
16555576
[PubMed - indexed for MEDLINE]
6.

Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.

Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group.

J Am Geriatr Soc. 2004 Dec;52(12):1981-7.

PMID:
15571531
[PubMed - indexed for MEDLINE]
7.

Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.

Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group.

Circ J. 2003 Apr;67(4):287-94.

PMID:
12655157
[PubMed - indexed for MEDLINE]
Free Article
8.

Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).

Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group.

Atherosclerosis. 2007 Apr;191(2):440-6. Epub 2006 Jun 12.

PMID:
16765358
[PubMed - indexed for MEDLINE]
9.

Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin.

Sasaki J, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Shimamoto K, Kono S, Itakura H; J-LIT Study Group.

Circ J. 2006 Jul;70(7):810-4.

PMID:
16799230
[PubMed - indexed for MEDLINE]
Free Article
10.

[Results of clinical epidemiology and intervention trial of hyperlipidemia in Japan].

Itakura H.

Nihon Rinsho. 2002 May;60(5):889-98. Japanese.

PMID:
12029990
[PubMed - indexed for MEDLINE]
11.

Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.

Saito Y, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Sasaki J, Shimamoto K, Itakura H.

J Atheroscler Thromb. 2010 Mar 31;17(3):270-7. Epub 2010 Jan 16.

PMID:
20081324
[PubMed - indexed for MEDLINE]
Free Article
12.

A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study.

Mizuno K, Nakamura H, Ohashi Y, Kaburagi T, Kitabatake A, Tochihara T, Hosoda S; JUST Study Investigators.

Clin Ther. 2004 Jun;26(6):878-88.

PMID:
15262458
[PubMed - indexed for MEDLINE]
13.

Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.

Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.

Curr Med Res Opin. 2006 May;22(5):823-35.

PMID:
16709304
[PubMed - indexed for MEDLINE]
14.

The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.

Sakamoto K, Sakamoto T, Ogawa H; Kumamoto Joint Research on Hypercholesterolemia Investigators.

Clin Ther. 2006 Jul;28(7):1012-21.

PMID:
16990079
[PubMed - indexed for MEDLINE]
15.

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.

Am J Cardiol. 2008 Feb 15;101(4):486-9. doi: 10.1016/j.amjcard.2007.09.095. Epub 2007 Dec 26.

PMID:
18312763
[PubMed - indexed for MEDLINE]
16.

[Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].

Kukharchuk VV, Bubnova MG, Katel'nitskaia LI, Nikitin IuP, Ol'binskaia LI; Multicenter Clinical Study Participants.

Kardiologiia. 2003;43(5):42-7. Russian.

PMID:
12891239
[PubMed - indexed for MEDLINE]
17.
18.
19.
20.

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).

Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan.

Atherosclerosis. 2008 Sep;200(1):135-40. doi: 10.1016/j.atherosclerosis.2008.06.003. Epub 2008 Jun 19. Erratum in: Atherosclerosis. 2009 May;204(1):233.

PMID:
18667204
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk